In vitro and in vivo stability of a highly efficient long-acting cocaine hydrolase
Year: 2024
Type: article
Abstract: It is recognized as a promising therapeutic strategy for cocaine use disorder to develop an efficient enzyme which can rapidly convert cocaine to physiologically inactive metabolites. We have designed and discovered a series of highly efficient cocaine hydrolases, including CocH5-Fc(M6) which is the currently known as the most efficient cocaine hydrolase with both the highest catalytic activity against (-)-cocaine and the longest biological half-life in rats. In the present study, we characterized the time courses of protein appearance, pH, structural integrity, and catalytic activity against cocaine in vitro and in vivo of a CocH5-Fc(M6) bulk drug substance produced in a bioreactor for its in vitro and in vivo stability after long-time storage under various temperatures (- 80, - 20, 4, 25, or 37 °C). Specifically, all the tested properties of the CocH5-Fc(M6) protein did not significantly change after the protein was stored at any of four temperatures including - 80, - 20, 4, and 25 °C for ~ 18 months. In comparison, at 37 °C, the protein was less stable, with a half-life of ~ 82 days for cocaine hydrolysis activity. Additionally, the in vivo studies further confirmed the linear elimination PK profile of CocH5-Fc(M6) with an elimination half-life of ~ 9 days. All the in vitro and in vivo data on the efficacy and stability of CocH5-Fc(M6) have consistently demonstrated that CocH5-Fc(M6) has the desired in vitro and in vivo stability as a promising therapeutic candidate for treatment of cocaine use disorder.
Source: Scientific Reports
Institution: University of Kentucky
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,590
Awards: Development of Long-acting Cocaine Hydrolase as a Treatment for Cocaine Abuse, Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning, Ghrelin Deacylase as a Treatment for Opioid Polysubstance Abuse, G5330388222, Development of a Cocaine-Metabolizing Enzyme for Drug Overdose Treatment, Development of a Long-acting Enzyme Therapy for Treatment of Cocaine Abuse, Validation of ghrelin hydrolysis as an effective approach to treatment of substance use disorders, Long-lasting cocaine-metabolizing enzyme for cocaine addiction treatment, Redesign of Butyrylcholinesterase for Cocaine Metabolism, G9000059500, G9000223770, G9000280494, Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning, Development of Long-acting Cocaine Hydrolase as a Treatment for Cocaine Abuse
OpenAlex ID: W4396851754
